Carlsmed, Inc., a MedTech company pioneering AI-enabled personalized spine surgery, today announced FDA 510(k) clearance for the aprevo® Cervical ACDF Interbody System. This milestone underscores Carlsmed’s commitment to advancing patient-specific spine surgery solutions that enhance outcomes and surgical precision.

3Laws, a leader in dynamic safety solutions for autonomous systems, has secured $4.1M in seed funding. The round is led by TenOneTen, with participation from the Amazon Industrial Innovation Fund. All pre-seed investors have chosen to maintain or increase their ownership in this round.

Wethos AI, the pioneering force in AI-driven team optimization, announced it has raised $7.5 million in a seed funding round led by Jeff Herbst at GFT Ventures. The investment underscores the growing recognition of Wethos AI's innovative approach to reshaping workplace dynamics in an AI-centric world. Seasoned investors in the round also include Miramar Digital Ventures, UCI Cove Fund and Capellas Partners.

Carlsmed, an AI-enabled personalized surgery Medtech company, announced today a $52.5M Series C funding round co-led by B Capital and U.S. Venture Partners. These proceeds will be used to accelerate the commercialization of the aprevo® personalized spine surgery platform for lumbar fusion procedures and the development of aprevo® for cervical fusions, which will launch in 2025.

Daasity, an e-commerce analytics and data company, secured $15 million in Series A funding as it continues developing its approach to helping consumer brands better leverage their customer data to make smarter decisions.